Clinical Application of BioCleanse Meniscus

NCT00659880 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2017-06-26

Study results available
· View outcomes & findings →

Summary

This study will follow patients after routine surgery of a meniscal allograft transplant.

Conditions

  • Tear of Meniscus of Knee

Interventions

OTHER

BioCleanse Meniscus

Subjects will undergo routine meniscal allograft transplant surgery.

Sponsors & Collaborators

  • RTI Surgical

    lead INDUSTRY

Principal Investigators

  • Jack Farr, MD · OrthoIndy -Orthopaedic Research Foundation, Inc

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00659880 on ClinicalTrials.gov